Status:
COMPLETED
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Lead Sponsor:
International Vaccine Institute
Collaborating Sponsors:
Aga Khan University
Wellcome Trust
Conditions:
Typhoid
Paratyphoid Fever
Eligibility:
All Genders
2-16 years
Phase:
PHASE4
Brief Summary
This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The ...
Detailed Description
Typhoid fever is a major cause of morbidity worldwide. The disease predominantly affects school-aged children, is more prevalent in urban areas, may last for several weeks and can lead to serious comp...
Eligibility Criteria
Inclusion
- Registered in the project census
- Age: 2-16 years
Exclusion
- Fever \>37.5 degrees Celsius, axillary
- Pregnancy
- Lactating
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
27231 Patients enrolled
Trial Details
Trial ID
NCT00125047
Start Date
October 1 2001
End Date
August 1 2007
Last Update
August 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University
Karachi, Pakistan